Clinical Trial Update: Pilot Study to Assess the Effects of AV608 on Irritable Bowel Syndrome [Phase 1]

View source ↗

Summary

A Phase 1 pilot study evaluating AV608 for irritable bowel syndrome has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome

Drugs mentioned

• AV608

Snippet

Sponsor: Avera Pharmaceuticals | Conditions: Irritable Bowel Syndrome (IBS) | Phase 1 | Status: TERMINATED